Skip to main content
- Funds
- Insights
- About Us
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
With the current blend of macro headwinds and tailwinds, we believe it is critical to keep a global growth equities portfolio well balanced. As quality-growth investors, we evaluate investments using four factors — quality, growth, valuation upside, and capital return — with varying emphasis based on where we are in the economic cycle. Wellington’s proprietary Global Cycle Index (Figure 1) recently peaked and is trending sideways following the largest economic bounce on record. In this environment, we weight each of our four factors equally as we rank stocks in our investment universe and believe that maintaining higher quality and valuation discipline is essential to navigating today’s volatility.
In this short outlook, we highlight how this market backdrop may impact growth companies, including areas that we think are well positioned for the year ahead.
Firstly, it’s important to evaluate the macro factors currently affecting growth equities. The combination of effective vaccines and treatments against COVID-19, unprecedented government monetary and fiscal stimulus worldwide, and positive consumer confidence drove economic growth this past year.
But the tailwinds from 2021 are now driving headwinds as inflation increases and the US Federal Reserve begins to taper bond purchases in 2022, raising interest rates. Notably, we believe the market will price in more persistent inflation, which may hit a 30-year high in September 2022. We expect economic growth to slow down in the first half of 2022 as higher prices for energy and other goods weigh on consumer confidence and squeeze real incomes unless wages rise enough to support reflation.
In our view, it is crucial to next consider how different growth companies will behave amid these diverse factors.
The effect of rising rates varies significantly across companies and sectors. On the positive side, high-quality growth financials may benefit from exposure to wider interest-rate spreads. For example, wealth management companies can charge higher fees on cash balances, banks’ net interest margins should expand as rates go up, and demand continues to increase for private equity investments that are uncorrelated with public equities.
On the other hand, when interest rates rise, valuation discipline becomes even more important, in our view. This is particularly true when investing in growth equities. Higher rates impact more expensive, higher-multiple stocks as their cost of capital rises. For instance, we see examples of this among some technology stocks. This is one reason why we view that valuation discipline is an essential input into our process. We typically look for stocks to have a minimum of 10% valuation upside potential and also seek to avoid exaggerated free-cash-flow yield valuation multiples. In addition, companies with more balance-sheet leverage and emerging markets countries with high levels of dollar-denominated debt may struggle in a higher-interest-rate environment. Our focus on high-quality companies generating strong free-cash-flow margins with low debt levels is therefore especially important in this environment.
Similarly, the impacts of inflationary pressures range widely across companies and sectors. Some can absorb higher cost inputs without sacrificing margins because they have the pricing power to pass these costs on to their customers. Such companies usually exist in the software and services, health care, data analytics, and industrials sectors. In our view, these businesses are attractive in this environment as they have pricing power because their products and services are unique and high value, improve efficiency, lower costs, and are mission critical for their customers.
Conversely, companies that sell products that are less differentiated or lower value-add may lack pricing power, particularly given the price transparency available online. For example, consumer staples companies are more vulnerable to today’s rising inflationary pressures. These companies absorb higher raw material and transportation costs without fully passing these costs on to their customers, resulting in lower margins. Wage inflation also puts margin pressure on companies with high labor costs, such as those in the consumer services or consulting sectors. Notably, leading companies with global scale are less susceptible to wage inflation as they have better technology platforms to hire and train people and recruit from different countries, which is more difficult for smaller companies.
Lastly, we believe China offers strong economic growth potential and investment opportunities in 2022. The country tightened liquidity with increased regulations during 2021. As a result, China’s increase in economic growth was low relative to other major countries, and its equities lagged. However, we believe China may still be offering investment opportunities and attractive valuations, as we expect the government to stimulate the economy in 2022 while the rest of the world tightens. Furthermore, we anticipate that China’s regulatory activity seen this past year will slow down.
In particular, we like consumer, internet, and health care companies in China as we think these sectors may benefit from secular government support for growth as well as an emerging middle class with discretionary income to spend on goods and services.
Today’s markets are influenced by strong macroeconomic forces, including government stimulus, rising interest rates, inflation, and regulation. As growth equity investors, we find it easier to navigate this volatile environment by adhering to our disciplined, structured philosophy and process. Looking to 2022 and beyond, we believe this approach to identifying potential companies with high quality, growth potential, valuation upside, and capital return to shareholders is especially important in this market.
Quality growth — a less volatile sweet spot?
Growth stocks can be volatile, especially when companies fail to meet expectations. However, high-quality growth companies can help mitigate downside risk while still offering potential for long-term outperformance. How can investors find the sweet spot?
An active investor’s guide to growth equities
Our experts offer their view on the current economic environment, explore best practices for investing in high-quality growth equities, and highlight where they see opportunity now.
Chart in Focus: The need to differentiate market growth from macro growth
Macro growth and earnings growth have been misaligned for the last 15 years, particularly in the US and China, but in opposite directions. For equity investors, what would be the key to identify real growth?
Four investment perspectives amid a pivotal US election
How can investors reposition portfolios for a pivotal but highly unpredictable US elections? Nick Samouilhan explores potential avenues in conversation with three leading portfolio managers.
Japan’s tech sector: Time for a reboot?
Japan's semiconductor industry has revived global interest in Japan's tech ecosystem. But we believe the dynamism of Japan's tech sector today doesn't start and end with electronics and semiconductors.
Chart in Focus: Broadening earnings growth signals healthy US equity market
Over the past year, the markets have seen the companies best poised to harness and benefit from new innovations within artificial intelligence rewarded accordingly. Can this signal more upside for the entire US equity market?
Beyond the hype: finding AI’s long-term winners
Our expert argues that a long-term mindset based on deep research can help to uncover evolving AI investment opportunities amid the hype.
Three ways to elevate your portfolio in 2024
As a new investment era takes shape, where should investors focus their attention in 2024? For multi-asset strategist Nick Samouilhan, three areas are top of mind: higher yields, the importance of stock selection and how to position for structural change.
Novel therapies changing the course of health care
Several new drug classes represent a growing investment opportunity set that could reshape the health care sector.
Asia Tech: Building the technology for everything, everywhere, all at once
Yash Patodia articulates the investment opportunities within generative AI and mixed reality - two themes that are supercharging the tech industry. He outlines how Asia is the bedrock of the innovation and where he believes the world’s future growth will be.
Activism – History and evolution in Japan
Investment Specialist Toshiki Izumi examines the history of shareholder activism in Japan, with particular emphasis on the differences between current and historical attitudes toward activism.
URL References
Related Insights